- April 1, 2014
-- ThermiAesthetics announced today that its CEO, Paul Herchman, will present at The Life Sciences and Healthcare Venture Summit
at the Digital Sandbox in New York City on April 2, 2014. Mr. Herchman will present ThermiAesthetics, one of the fastest growing medical and aesthetic companies in 2013 and their ThemiRF™ technology platform, which allows physicians to provide effective solutions for many aesthetic applications with a single injectableRF treatment. He will provide an overview of ThermiAesthetics’
accomplishments and discuss plans for taking the company forward.
The Life Science and Healthcare Venture is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of early stage and emerging growth companies, university researchers, incubators and premier service providers.About ThermiAesthetics
The ThermiAesthetics flagship product is the ThermiRF Temperature Controlled Radio Frequency Generator System and is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis; and to create lesions in nervous tissue. ThermiRF is an advanced technology using finely controlled thermal energy. It is a multi-use platform, which promotes increased patient safety and clinical effectiveness, while providing versatile solutions for physicians serving the aesthetic market.
ThermiRF features a unique temperature control feature and uses proprietary hand pieces, which are designed for specific medical applications. These include a variety of disposal RF electrodes and cannulas and reusable non-invasive hand pieces.